PeptIQ app

Track your peptide protocols in PeptIQ

Log injections, vial supply, and reminders. Use peptiq.io calculators when you need math on the web.

Get the appOpen web app

iOS, Android, and web

Partner clinic

Licensed clinics can help you explore MOTS-C treatment options online — if it's a fit for you.

Partner link. PeptIQ may earn a referral fee. Not medical advice.

Ask PeptIQ

Two taps on our guided quiz, then keep going in iMessage with sources — not Instagram screenshots.

Start the quizOr try Peptide X Quiz →
@6thgradeleveltutorials post

Audited November 1, 2026 · Post from Dec 7, 2025

⚠️Overstated

The creator's claims about 'Matsi' cannot be verified because no peer-reviewed literature, clinical trials, or PubMed records exist for a peptide by that name. However, if 'Matsi' refers to MOTS-c (Mitochondrial-derived Oligopeptide that Enhances Stress Resistance-C), the metabolic and insulin-response claims are directionally supported by an active Phase 2a human clinical trial (NCT07505745) currently recruiting participants with prediabetes and overweight/obesity. The claim about improved endurance, blood sugar, and energy efficiency is supported in direction but overstated in certainty—the trial is ongoing and published human efficacy data is not yet available. All other claims (stress resilience, fat oxidation, AMPK activation) lack published evidence. Immediate clarification on the peptide's actual identity and the basis for the 'Matsi' nomenclature would be necessary for a complete evaluation.

Share this audit

One link — full verdict, every claim, and PubMed citations included.

peptiq.io/check/20fd8e7e…

Shareable link includes the full verdict, claims, and PubMed citations.

Post captionshow

MOTS C Explained in 60 Seconds | Simple Breakdown #sports #science #brain

Video transcriptshow

Here's the easiest way to understand Matsi in under one minute. Matsi is a tiny peptide your mitochondria make to help your body handle stress and create energy. Think of it like a backup generator for your cells when things get tough. It helps your body use sugar better, burn fat for fuel, and stay steady when you're tired or under pressure. It does this by activating pathways that boost your met…

Show full video transcript

abolism and support exercise performance. Matsi also helps your body respond better to insulin, which is exactly why it's being studied for weight loss, metabolic health, and even anti-aging benefits. But here's the reality check. It's still experimental. It's not approved by the FDA, and it's banned in competitive sports for its performance-enhancing potential. Still, the reason people talk about Mott C is its massive potential to improve endurance, support healthy blood sugar, and help the body make energy far more efficiently. If you want peptides explained in simple terms, subscribe for

Show less

Claim breakdown

6 claims
1

“Matsi activates pathways that boost your metabolism and support exercise performance.”

❌No Evidence

No peer-reviewed studies or clinical trials found linking 'Matsi' to AMPK pathway activation, metabolic boost, or exercise performance enhancement. The peptide has no published literature supporting these claims.

2

“Matsi is a tiny peptide your mitochondria make to help your body handle stress and create energy.”

❌No Evidence

No peer-reviewed literature, clinical trials, or PubMed abstracts found specifically for a peptide called 'Matsi' or its purported mitochondrial origin and stress-response mechanism. The peptide name does not appear in scientific databases.

3

“Matsi helps your body use sugar better, burn fat for fuel, and stay steady when you're tired or under pressure.”

❌No Evidence

No peer-reviewed studies or clinical trials found specifically linking 'Matsi' to improved glucose utilization, fat oxidation, or fatigue resilience. The peptide itself has no published mechanistic or efficacy data.

4

“Matsi also helps your body respond better to insulin.”

✅Supported

Human Phase 2a clinical trial (NCT07505745) is actively recruiting to evaluate MOTS-c (mitochondrial-derived peptide) efficacy, safety, and pharmacodynamics in adults with prediabetes and overweight/obesity—directly supporting the concept that a mitochondrial peptide can improve insulin response and metabolic health. A second human observational study (NCT04027712) noted downregulation of MOTS-c in patients with type 2 diabetes and coronary artery disease, further linking the peptide to glucose metabolism.

5

“Matsi is being studied for weight loss, metabolic health, and anti-aging benefits.”

✅Supported

Human Phase 2a clinical trial (NCT07505745) is actively studying MOTS-c for weight loss and metabolic health in adults with prediabetes and overweight/obesity. PeptIQ internal knowledge base documents MOTS-c as a mitochondrial peptide studied for metabolic and longevity benefits, supporting the claim's direction—though formal anti-aging outcome data in humans is not yet published.

6

“Matsi has the potential to improve endurance, support healthy blood sugar, and help the body make energy far more efficiently.”

⚠️Overstated

Human Phase 2a clinical trial (NCT07505745) is studying MOTS-c (presumed to be the peptide referenced) for metabolic and glucose benefits in prediabetes and obesity, supporting the concept of improved endurance, blood sugar stability, and energy efficiency. However, the trial is still actively recruiting and results are not yet published; no published human data currently demonstrate that these benefits are achieved or the degree of efficiency gain ('far more efficiently' is not quantified in available evidence).

Audit another post

Instagram, TikTok, X, Reddit, or paste text directly.

New audit

Track your protocols

Dosing, logging, and reminders in the app.

Get the app

This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.

Report an error